Kimberly Freitas, NP
Adult Health · Portland, ORNPI 1598542482
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $326 of the $425 with a category attached, or 76.7%. 11 manufacturers reported payments, led by Johnson & Johnson at 28.5% of the total. 2025 is the largest year on record at $254, 6.1 times the $42 reported in 2023.
Across 16 payments — averaging $26.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$121
- Genentech USA, Inc.$51
- Incyte Corporation$48
- Caris MPI, Inc.$44
- AstraZeneca$40
- AbbVie$30
- plus $91 from 5 others
What the payments were for
- Food & beverage$32677%
- Education$9923%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 2 | $121 |
| Genentech USA, Inc. | 2 | $51 |
| Incyte Corporation | 2 | $48 |
| Caris MPI, Inc. | 2 | $44 |
| AstraZeneca | 2 | $40 |
| AbbVie | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Tempus AI, Inc | 1 | $20 |
| Novartis | 1 | $17 |
| Pfizer | 1 | $15 |
| Eisai Inc. | 1 | $15 |
How this compares
$425 in reported general payments places this provider in the 55th percentile of 96 adult health providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Morphine Sulfate ErMorphine Sulfate | 13 | $285 |
| Gabapentin | 12 | $127 |
| Oxycodone Hcl | 11 | $101 |
| Potassium Chloride | 16 | $90 |
Paid to pharmacies, not to this prescriber.
Other adult health in Portland
- Lakshi AldredgePortland$393K
- Erin MyklebustPortland$14K
- Yasmine LeePortland$11K
- Terri WarrenPortland$10K
- Michael DuprePortland$3K
- Carrie StonePortland$2K
- Lisa EngerPortland$2K
- Diana GliddenPortland$2K
- Amy RuhoffPortland$1K
- Diane OsbornPortland$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.